Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Coronary artery disease

Variation in ischaemic heart disease between EU countries

Nature Reviews Cardiology volume 10, pages 555–556 (2013)Cite this article

Subjects

Ischaemic heart disease (IHD) causes a large number of deaths in the European Union, but a new study reveals important inequalities in IHD mortality between countries. Surveillance systems might help to identify these differences and define tailored treatment strategies, so that the burden of IHD can be reduced across Europe.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Mortality from ischaemic heart disease in European countries.

References

  1. Nichols, M., Townsend, N., Scarborough, P. & Rayner, M. Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980–2009 Eur. Heart J. http://dx.doi.org/10.1093/eurheartj/eht159.

  2. OECD. Health at a Glance: Europe 2012 [online], (2012).

  3. Kotseva, K. et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur. J. Cardiovasc. Prev. Rehabil. 16, 121–137 (2009).

    Article  Google Scholar 

  4. Puymirat, E. et al. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA 308, 998–1006 (2012).

    Article  CAS  Google Scholar 

  5. Jernberg, T. et al. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA 305, 1677–1684 (2011).

    Article  CAS  Google Scholar 

  6. Wagner, A. et al. Trends in coronary heart disease in France from 2000 to 2007. BEH 40–41, 414–419 (2011).

    Google Scholar 

  7. Beck, F., Guignard, R., Richard, J. B., Wilquin, J. L. & Perreti-Watel, P. Increasing trends in smoking in France: main results of the French Health Barometer, France 2010. BEH 20–21, 230–233 (2011).

    Google Scholar 

  8. Berry, J. D. et al. Lifetime risks of cardiovascular disease. N. Engl. J. Med. 366, 321–329 (2012).

    Article  CAS  Google Scholar 

  9. Komajda, M. et al. Championing cardiovascular health innovation in Europe. Eur. Heart J. http://dx.doi.org/10.1093/eurheartj/eht211.

Download references

Author information

Authors and Affiliations

  1. Cardiology Department, CCUL, CAML, University of Lisbon, Avenue Professor Egas Moniz, 1600-190 Lisbon, Portugal

    Fausto J. Pinto

Authors
  1. Fausto J. Pinto
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pinto, F. Variation in ischaemic heart disease between EU countries. Nat Rev Cardiol 10, 555–556 (2013). https://doi.org/10.1038/nrcardio.2013.116

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2013.116

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing